Home
Convention Main Focus
Committees
Speakers
Submitted Presentations
More
Programme Schedule
Overall Programme
Invitation of Abstract (Closed)
Professional Accreditation
Convention Registration (Closed)
Sponsorship
Sponsors
Photo Gallery
Attendance Certificate
Contact Us
Vote (closed)
Login
簡體
繁體
EN
HA Convention 2021
HA Convention 2021
Toggle navigation
Home
Convention Main Focus
Committees
Speakers
Submitted Presentations
More
Programme Schedule
Overall Programme
Invitation of Abstract (Closed)
Professional Accreditation
Convention Registration (Closed)
Sponsorship
Sponsors
Photo Gallery
Attendance Certificate
Contact Us
Vote (closed)
Login
簡體
繁體
EN
HA Convention 2021
Login
簡體
繁體
EN
Login
Prof. David SC HUI
The Chinese University of Hong Kong
Overview
CV
David Hui is the Chairman & Stanley Ho Professor of Respiratory Medicine under the Department of Medicine & Therapeutics, in addition to his role as the Director of the Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong (CUHK). He undertook undergraduate medical training at the University of New South Wales in 1980-84 followed by postgraduate training in Respiratory & Sleep Medicine in Sydney, Australia. He has joined the CUHK as an academic clinician since 1998 and is based at the Prince of Wales Hospital, HK where a major outbreak of SARS occurred in 2003. Since 2004, he has frequently served as an advisor to the WHO on the clinical management of emerging severe acute respiratory infections (SARI) including avian influenza, pandemic influenza, MERS and COVID-19. He joined urgent WHO missions for the investigation of MERS outbreaks in Riyadh and South Korea in 2013 and 2015 respectively. He has served as an expert advisor to the Chief Executive, HKSAR government on COVID-19 since Jan 2020 and the Chairman of the Scientific Committee on Emerging & Zoonotic Diseases under the Center for Health Protection since Sept 2019. Prof Hui has published well over 350 peer-reviewed journal articles and 24 book chapters. His research interests include the clinical management of SARI, safety of respiratory therapy in the post SARS era, prevention of nosocomial transmission of respiratory infections, and study of ventilation/exhaust design in hospital isolation room.
Speaking Engagement
1. Plenary Session I - COVID-19: Control And Policy
-
03 May, 2021
Prof Nan-shan ZHONGDirector, National Clinical Research Center for Respiratory Disease, The People's Republic of ChinaCOVID-19: Control and Policy &nd...
Forgot your Password?
Disconnected from server
You are disconnected from the server. The changes you made may not be saved. Please check when connected.